Newsroom Navigation

Contact Info:
Office of Public Affairs
2000 Circle of Hope,
Salt Lake City, UT 84112

public.affairs@hci.utah.edu

801-587-7639

Recent News

Salt Lake City congregation embraces the mysteries of both science and religion
In The Media

Salt Lake City congregation embraces the mysteries of both science and religion

For Chris Jensen, science and religion are like "the marriage of two mysteries." A biologist and senior laboratory specialist with the Huntsman Cancer Institute, Jensen said his work enriches and reinforces his Lutheran faith. Science looks at objects large and small, he said, and God is present in all of them. "Things just work really, really elegantly and beautifully together," he said. "Whether you take faith as the answer to that or not is individual." Jensen is a member of Salt Lake City's Mount Tabor Lutheran Church, where the interplay between science and faith — often seen in conflict — is encouraged and celebrated.

Read More

In The Media

Madison Memorial, Huntsman Institute partner up

Madison Memorial Hospital officials last week announced a new affiliation with the Huntsman Cancer Institute at the University of Utah. Madison Memorial Hospital is a 69-bed, full-service medical facility. Huntsman Cancer Institute is one of the world’s top academic research and cancer treatment centers, a Madison Memorial news release said. Madison Memorial’s partnership with the Salt Lake City-based Institute will extend its resources to Madison County and the surrounding communities, the release said. The agreement, which formalizes a long tradition of collaboration between the two entities, sets the stage for Madison Memorial to provide improved patient access to cancer specialties including clinical trials and other research efforts, the release said.

Read More

Huntsman Cancer Institute One of the Top in the Nation; University of Utah Hospital Best in Utah, according to latest U.S. News & World Report Rankings
In The Media

Huntsman Cancer Institute One of the Top in the Nation; University of Utah Hospital Best in Utah, according to latest U.S. News & World Report Rankings

U.S. News & World Report has released its 2016-2017 Best Hospital Rankings and named University of Utah’s Huntsman Cancer Institute (HCI) one of the top 50 cancer hospitals in the country. “We are extremely pleased to be recognized by U.S. News & World Report as one of the nation’s top cancer hospitals,” said Mary Beckerle, CEO and director of HCI. “Cancer touches the lives of everyone, and this recognition reflects our efforts to relieve the burden of this disease on our patients and their families through excellent patient care and robust scientific research. We are motivated by the idea that it is possible to defeat cancer.”

Read More

Huntsman Cancer Institute One of the Top in the Nation; University of Utah Hospital Best in Utah, according to latest U.S. News & World Report Rankings
In The Media

Huntsman Cancer Institute One of the Top in the Nation; University of Utah Hospital Best in Utah, according to latest U.S. News & World Report Rankings

SALT LAKE CITY—U.S. News & World Report has released its 2016-2017 Best Hospital Rankings and named University of Utah’s Huntsman Cancer Institute (HCI) one of the top 50 cancer hospitals in the country. “We are extremely pleased to be recognized by U.S. News & World Report as one of the nation’s top cancer hospitals,” said Mary Beckerle, CEO and director of HCI. “Cancer touches the lives of everyone, and this recognition reflects our efforts to relieve the burden of this disease on our patients and their families through excellent patient care and robust scientific research. We are motivated by the idea that it is possible to defeat cancer.”

Read More

Therapy on four legs
In The Media, HCI News

Therapy on four legs

Every week, a special visitor appears at Huntsman Cancer Institute (HCI). His job? To cheer up patients fighting cancer and their family members. His name is Misio, and he’s a therapy dog with Intermountain Therapy Animals. Kathy McNulty, a volunteer with the organization, is Misio’s escort. Kathy says Misio has only been coming to HCI for a few months, but she can already see the difference he’s making for patients and their families. “Over and over, I’ve seen tears turn to smiles,” she says. “Misio takes their minds off the procedures.”

Read More

Better health before surgery leads to better outcomes
HCI News

Better health before surgery leads to better outcomes

Surgery is part of cancer treatment plans in many cases. While surgery is an important part of treatment, recovery from surgery has a major impact on overall health. Strong for Surgery is a program that focuses on making small changes in health before surgery. Making these changes, even just before surgery, can make a big difference in recovery.

Read More

Chemoprevention for People at High Risk
In The Media, HCI News

Chemoprevention for People at High Risk

Individuals with familial adenomatous polyposis (FAP) have a nearly 100 percent chance of developing colon cancer and often undergo surgery to remove the colon so cancer can’t develop there. A new medication being tested in a clinical trial lead by Jewel Samadder, MD, has shown promising results. The first round of testing shows that in less than six months, half of the patients who received medication saw a nearly 70% regression of polyps. For some, polyps disappeared completely.

Read More

Why Do Elephants Almost Never Get Cancer?
In The Media, HCI News

Why Do Elephants Almost Never Get Cancer?

P53 – one gene that may hold the key. Humans have two copies, but some people are missing a copy. For individuals with only one working copy of P53, their lifetime risk of cancer is nearly 100 percent. Elephants, after 55 million years of evolution, have 40 copies of the P53 gene. Those extra copies protect elephant’s cells from cancer by eliminating cells that develops any type of mutation that could go on to become cancer.

Read More

In The Media

Hope for a cancer-free future: chemoprevention for people at high risk

Kathy and her niece, Rhonda, regularly make the trip from their small town in Illinois, to Salt Lake City. They don’t come to see family and friends or to cheer for the University of Utah. They come to Huntsman Cancer Institute (HCI) to be tested for polyps in their small intestines. Kathy and Rhonda both have familial adenomatous polyposis (FAP), an inherited genetic disease. FAP causes hundreds of polyps to form throughout the small and large intestines. Any polyp in the intestine has the potential to become cancer. With so many polyps, people with FAP have a nearly 100-percent chance of developing colon cancer. Patients with FAP often undergo surgery to remove the colon so cancer can’t develop there.

Read More

In The Media

I.V.F. Does Not Raise Breast Cancer Risk, Study Shows

Women undergoing in vitro fertilization have long worried that the procedure could raise their risk for breast cancer. After all, the treatment requires temporarily increasing levels of certain sex hormones to five or 10 times the normal. Two of those hormones, estrogen and progesterone, can affect the course of certain kinds of breast cancer.

Read More

In The Media

Cases of Aggressive Prostate Cancer on the Rise, Research Finds

Cases of aggressive prostate cancer appear to be on the rise, researchers reported Tuesday. The good news is it's still rare for prostate cancer to spread. Just 3 percent of cases have already started spreading when men are diagnosed and prostate cancer overall has not become more common, the team found. And the American Cancer Society strongly questioned the findings and the methods used to get them.

Read More

Madison Memorial teams up with Huntsman Cancer Institute on clinic
In The Media

Madison Memorial teams up with Huntsman Cancer Institute on clinic

Madison Memorial Hospital and the the Huntsman Cancer Institute have teamed up to better provide cancer patients with convenient and closer services. The goal of the project is to give local patients an easier commute, instead of traveling miles out of town for cancer services. CEO of Madison Memorial Hospital Rachel Gonzales said the last thing you want to do when your sick is think about the burden of traveling far. "You're not feeling well, you're stress you're afraid. You just received the scariest diagnosis of your life. And you're having to travel and leave your family often. So that travel time just adds more stress," Gonzales said. After all, the treatment requires temporarily increasing levels of certain sex hormones to five or 10 times the normal. Two of those hormones, estrogen and progesterone, can affect the course of certain kinds of breast cancer.

Read More

In The Media

Physician-assisted suicide, euthanasia: increasingly legal but still rare

Legalized euthanasia and physician-assisted suicide are mainly used by patients with cancer, but remain rare, according to a new analysis of such programs. In the last year alone, California has legalized physician-assisted suicide, Canada legalized both physician-assisted suicide and euthanasia, and Colombia performed its first legal euthanasia, said John Urwin, a study author from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia. "In order to inform current debates, it's imperative to understand current laws and practices."

Read More

In The Media

First Drug Target Identified for Children with Rare Type of Brain Tumor

Primitive neuroectodermal tumors (PNETs) are the largest group of malignant brain tumors in children. They can arise from the brain's cerebellum or, more rarely, from tissue located throughout the central nervous system (CNS). Little is known about how CNS-PNETs develop, although these tumors are more aggressive than other PNETs and have an overall survival rate of only about 20 percent. In a new study, researchers for the first time have identified a possible target for a new CNS-PNET therapy.

Read More

In The Media

Researchers identify new drug target for treating children with CNS-PNET

Primitive neuroectodermal tumors (PNETs) are the largest group of malignant brain tumors in children. They can arise from the brain's cerebellum or, more rarely, from tissue located throughout the central nervous system (CNS). Little is known about how CNS-PNETs develop, although these tumors are more aggressive than other PNETs and have an overall survival rate of only about 20 percent. In a new study, researchers for the first time have identified a possible target for a new CNS-PNET therapy.

Read More

Navigating Through Cancer
HCI News

Navigating Through Cancer

Eduardo Ayala was 17 years old when he was diagnosed with testicular cancer. He is fluent in English and Spanish, but his parents speak only Spanish. Eduardo and his family came to HCI from Nevada for his treatments. It is one of the five Mountain West states at the core of HCI’s service area. Cancer has a language all its own and it’s that much harder if English is not your first language. That’s where Guadalupe Tovar, a health educator and patient navigator at Huntsman Cancer Institute (HCI), comes in. She helps Hispanic families navigate their cancer care.

Read More

Huntsman Cancer Institute Investigator Receives Leadership Award from the National Cancer Institute
News

Huntsman Cancer Institute Investigator Receives Leadership Award from the National Cancer Institute

The National Cancer Institute’s (NCI) Cancer Clinical Investigator Team Leadership Awards recognize and support outstanding clinical investigators at NCI-Designated Cancer Centers who participate extensively in NCI- funded collaborative clinical trials and whose leadership, participation, and activities promote a culture of successful clinical research. Established in 2009, the awards are intended to help retain investigators in academic clinical research careers. This year, 13 investigators nationwide, including Theresa Werner, MD, Huntsman Cancer Institute (HCI) investigator and University of Utah assistant professor of medicine have received the award.

Read More

Join Mark Koelbel and Timp Harley for the 2016 Ride For Life
In The Media

Join Mark Koelbel and Timp Harley for the 2016 Ride For Life

Salt Lake City — (KUTV) The 2016 Ride for Life is scheduled for Saturday July 9th and proceeds will benefit the Huntsman Cancer Institute. Tickets can be purchased at the Timpanogas Harley Davidson store in Lindon. The ride will start there and then end at the USANA Ampitheater.

Read More


Our media relations representatives are here to help reporters Monday-Friday, 7:30 am-5 pm.

Debby Rogers
Public Affairs Manager
Phone: 801-587-7639
debby.rogers@hci.utah.edu

Amie Parker
Public Relations Associate
Phone: 801-213-5755
amie.parker@hci.utah.edu

Jill Woods
Administrative Assistant
Phone: 801-585-5321
Fax: 801-585-0900
jill.woods@hci.utah.edu

After-hours calls: Reporters calling before or after business hours on an urgent matter can page the University of Utah Health on-call media relations representative at 801-581-7387 and press 1.